About: RMSD of protein Cα atoms of SARS-COv-2 Mpro (pink)and compounds (grayish green) during 100 ns of MD simulation. (A) Mpro– Akuammicine compex (B) Mpro– N-Oxide and N3 pepeide complex.

6LU7

In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease 2

Information

Details.

Scientist
Thrigulla Saketh Ram 1, Manne Munikumar 2, Vankudavath Naik Raju 3, Parasannanavar Devaraj 4, Naveen Kumar Boiroju 4, Rajkumar Hemalatha 4, P V V Prasad 1, Manohar Gundeti 5, Brijesh S Sisodia 6, Sharad Pawar 7, G P Prasad 7, Mukesh Chincholikar 8, Sumeet Goel 8, Anupam Mangal 8, Sudesh Gaidhani 8, N Srikanth 8, K S Dhiman 8
Protein
SARS-CoV-2 main protease
Ligand
Akuammicine compex , N-Oxide and N3 pepeide complex
Simulation Duration
100ns
InChIKey
NFV(YDJGNLIYQSXAAM-UHFFFAOYSA-N) LPV(KJHKTHWMRKYKJE-SUGCFTRWSA-N ) DRV (CJBJHOAVZSMMDJ-HEXNFIEUSA-N ) RTV(NCDNCNXCDXHOMX-XGKFQTDJSA-N) RBV (IWUCXVSUMQZMFG-AFCXAGJDSA-N )
SMILES
NFV (N(=[V])F) LPV(CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O) DRV(CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N ) RTV(CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O ) RBV (C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N )
Molecular Formula
NFV(FNV) LPV(C37H48N4O5) DRV(C27H37N3O7S) RTV (C37H48N6O5S2) RBV (C8H12N4O5)
Protein Details
Mpro, a cysteine protease plays a critical role in viral protein maturation by cleaning proproteins after their translation into the host cell cytosol. The inhibition of viral protease can reduce the assembly of mature viral particles.
Ligand Details
Works by decreasing the amount of HIV in the blood. Used in treatment of HIV.
Attachments